RxDoctor Payments Data

Alexis Rivera-Davila, MD

Cardiology · Fajardo, PRNPI 1013017508

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Johnson & Johnson at 32.9% of the total. Reporting peaked in 2021 at $850 and has fallen 82.1% since, to $152 in 2025.

$3,944in general payments, 2019–2025

Across 91 payments — averaging $43.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Boehringer Ingelheim$607
  • Abbott$384
  • Boston Scientific$284
  • E.r. Squibb & Sons, L.L.C.$245
  • Medtronic$242
  • plus $884 from 7 others

What the payments were for

  • Food & beverage$3,939100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson43$1,297
Boehringer Ingelheim9$607
Abbott4$384
Boston Scientific3$284
E.r. Squibb & Sons, L.L.C.5$245
Medtronic2$242
PBG Puerto Rico LLC10$215
AstraZeneca7$204
Amgen3$158
Impulse Dynamics (USA) Inc.1$122
Edwards Lifesciences1$115
Bayer Puerto Rico Inc.2$50
Chiesi USA, Inc.1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few cardiology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$11,201
Medicare patients
59
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$54,761
XareltoRivaroxaban61$38,952
JardianceEmpagliflozin17$11,608
EntrestoSacubitril/Valsartan14$9,743
Candesartan Cilexetil34$3,904
Losartan Potassium274$2,515
SynthroidLevothyroxine Sodium27$2,436
Metoprolol Succinate124$1,756
Atorvastatin Calcium140$1,576
ClopidogrelClopidogrel Bisulfate85$913
Doxazosin Mesylate50$910
Isosorbide Mononitrate ErIsosorbide Mononitrate53$728
Diltiazem 24hr Er (Cd)Diltiazem Hcl21$726
Amlodipine Besylate142$596
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide34$583

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$1,297$38,95261 claims
Boehringer IngelheimJardiance$607$11,60817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few cardiology providers in Puerto Ricoon file to place this against a meaningful peer group, so we don't.

Other cardiology in Fajardo

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →